查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577003

动物保健市场、机会、成长动力、产业趋势分析与预测，2024-2032

Animal Healthcare Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 235 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球动物保健市场价值为 1,861 亿美元，预计 2024 年至 2032 年复合年增长率为 6%。根据世界动物基金会的数据，全球有近3.73亿隻宠物猫和4.71亿隻宠物狗。人畜共通传染病的增加以及人们对动物健康重要性的认识不断提高，正在推动对预防性保健产品和服务的需求。

动物中肥胖、糖尿病和癌症等慢性疾病的流行增加了对先进兽医诊断和治疗的需求。美国兽医协会 (AVMA) 报告称，大约四分之一的狗会罹患肿瘤，10 岁以上的狗中近一半会罹患癌症。

整个产业分为产品、动物类型、配销通路和地区。

市场依产品分为药品、医疗器材及兽医服务。 2023年，兽医服务占最高市场份额，达75.9%。兽医服务包括预防保健、诊断、治疗、手术、牙科护理和紧急服务。它们还包括美容和日托服务。人畜共通传染病盛行率的上升以及为确保食品安全而对牲畜进行预防性医疗保健的需求正在推动该领域的成长。

动物保健市场依动物类型分为伴侣动物和家畜动物。伴侣动物细分市场在 2023 年创造了最高收入，达到 1,132 亿美元，预计在 2024 年至 2032 年期间将大幅成长。这部分包括狗、猫、马和其他伴侣动物。宠物人性化的趋势，即宠物被视为家庭成员，正在推动其医疗保健需求的支出增加。宠物拥有量的增加、可支配收入的增加以及兽医医疗保健服务的进步进一步促进了该细分市场的成长。

北美动物保健产业在 2023 年占最大份额，达到 38.9%，预计在预测期内复合年增长率为 5.5%。强劲的市场份额归因于其完善的兽医医疗保健基础设施、高宠物收养率、大量牲畜数量以及对动物健康和保健的日益关注。可支配收入水准的提高导致宠物保健产品和服务的支出增加，进一步推动市场成长。主要市场参与者的存在以及兽医诊断和治疗领域持续的技术进步也可能有助于在动物保健行业中占据主导地位。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 宠物数量不断增加
      • 政府和公共组织加强对动物照护的支持
      • 对网路兽药局的需求不断增长
      • 动物保健支出增加
    • 产业陷阱与挑战
      • 与动物保健药物相关的高成本
      • 农村地区的准入有限
  • 成长潜力分析
  • 监管环境
    • 北美洲
      • 我们
      • 加拿大
    • 欧洲联盟
    • 亚太地区
      • 日本
      • 中国
  • 技术景观
  • 报销场景
  • 动物保健产业的创投场景
  • 动物保健产业的经济影响
  • 差距分析
  • 消费者行为趋势
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2018 - 2032 年

  • 主要趋势
  • 药品
    • 药品
      • 抗寄生虫药
      • 消炎剂
      • 抗感染药
      • 其他药品
    • 疫苗
      • 改良活疫苗 (MLV)
      • 灭活灭活疫苗
      • 其他疫苗
    • 药用饲料添加剂
      • 抗生素
      • 维生素
      • 胺基酸
      • 酵素
      • 抗氧化剂
      • 益生元和益生菌
      • 矿物质
      • 其他药物饲料添加剂
  • 医疗器材
    • 兽医诊断设备
    • 兽医麻醉设备
    • 兽医病人监护设备
    • 兽医手术设备
    • 兽医耗材
    • 其他医疗器材
  • 兽医服务

第 6 章：市场估计与预测：按动物类型，2018 - 2032

  • 主要趋势
  • 伴侣动物
    • 狗
    • 猫
    • 马匹
    • 其他伴侣动物
  • 畜牧动物
    • 家禽
    • 猪
    • 牛
    • 鱼
    • 其他家畜动物

第 7 章：市场估计与预测：按配销通路，2018 年 - 2032 年

  • 主要趋势
  • 兽医院药房
  • 电子商务
  • 零售药房

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 波兰
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 台湾
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 海湾合作委员会国家
    • 以色列
    • 中东和非洲其他地区

第 9 章：公司简介

  • B. Braun Vet Care (B Braun Melsungen AG)
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Endovac Animal Health
  • HIPRA
  • IDEXX Laboratories
  • Merck and Co
  • Medtronic plc
  • Neogen Corporation
  • Sklar Surgical Instruments
  • Symrise
  • Vetoquinol SA
  • Virbac SA
  • Zoetis, Inc.
简介目录
Product Code: 735

The Global Animal Healthcare Market was valued at USD 186.1 billion in 2023 and is projected to grow at a CAGR of 6% from 2024 to 2032. Increasing pet ownership rates are driving higher spending on pet healthcare. According to the World Animal Foundation, there are nearly 373 million pet cats and 471 million pet dogs globally. The rise in zoonotic diseases and growing awareness of animal health importance are boosting demand for preventive healthcare products and services.

The prevalence of chronic diseases in animals, such as obesity, diabetes, and cancer, is increasing the need for advanced veterinary diagnostics and therapeutics. The American Veterinary Medical Association (AVMA) reports that approximately 1 in 4 dogs will develop neoplasia, and nearly half of dogs over 10 years old will develop cancer.

The overall industry is divided into product, animal type, distribution channel, and region.

The market is segmented by product into pharmaceuticals, medical devices, and veterinary services. In 2023, veterinary services held the highest market share at 75.9%. Veterinary services encompass preventive care, diagnostics, treatments, surgeries, dental care, and emergency services. They also include grooming and day-care services. The rising prevalence of zoonotic diseases and the need for preventive healthcare in livestock to ensure food safety are driving this segment's growth.

The animal healthcare market is classified by animal type into companion animals and livestock animals. The companion animals segment generated the highest revenue of USD 113.2 billion in 2023 and is expected to grow significantly during 2024-2032. This segment includes dogs, cats, horses, and other companion animals. The trend of pet humanization, where pets are treated as family members, is driving higher spending on their healthcare needs. Increasing pet ownership, rising disposable incomes, and advancements in veterinary healthcare services are further contributing to segment growth.

North America animal healthcare industry held the largest share at 38.9% in 2023 and is anticipated to grow at a 5.5% CAGR over the forecast period. The strong market share is due to its well-established veterinary healthcare infrastructure, high pet adoption rates, large livestock population, and a growing focus on animal health and wellness. Increased disposable income levels have led to higher spending on pet healthcare products and services, further driving market growth. The presence of key market players and ongoing technological advancements in veterinary diagnostics and therapeutics may also contribute to dominance in the animal healthcare industry.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing population of pet animals
      • 3.2.1.2 Increasing support offered by government and public organizations for animal care
      • 3.2.1.3 Growing demand for online veterinary pharmacies
      • 3.2.1.4 Increase in animal healthcare expenditure
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with animal health drugs
      • 3.2.2.2 Limited access in rural areas
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
      • 3.4.1.1 U.S.
      • 3.4.1.2 Canada
    • 3.4.2 European Union
    • 3.4.3 Asia Pacific
      • 3.4.3.1 Japan
      • 3.4.3.2 China
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Venture capitalist scenario in animal health industry
  • 3.8 Economic impacts of the animal health industry
  • 3.9 Gap analysis
  • 3.10 Consumer behaviour trends
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Pharmaceuticals
    • 5.2.1 Drugs
      • 5.2.1.1 Antiparasitic
      • 5.2.1.2 Anti-inflammatory
      • 5.2.1.3 Anti-infectives
      • 5.2.1.4 Other drugs
    • 5.2.2 Vaccines
      • 5.2.2.1 Modified live vaccines (MLV)
      • 5.2.2.2 Killed inactivated vaccines
      • 5.2.2.3 Other vaccines
    • 5.2.3 Medicated feed additives
      • 5.2.3.1 Antibiotics
      • 5.2.3.2 Vitamins
      • 5.2.3.3 Amino acids
      • 5.2.3.4 Enzymes
      • 5.2.3.5 Antioxidants
      • 5.2.3.6 Prebiotics and probiotics
      • 5.2.3.7 Minerals
      • 5.2.3.8 Other medicated feed additives
  • 5.3 Medical devices
    • 5.3.1 Veterinary diagnostic equipment
    • 5.3.2 Veterinary anesthesia equipment
    • 5.3.3 Veterinary patient monitoring equipment
    • 5.3.4 Veterinary surgical equipment
    • 5.3.5 Veterinary consumables
    • 5.3.6 Other medical devices
  • 5.4 Veterinary services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Companion animals
    • 6.2.1 Dogs
    • 6.2.2 Cats
    • 6.2.3 Horses
    • 6.2.4 Other companion animals
  • 6.3 Livestock animals
    • 6.3.1 Poultry
    • 6.3.2 Swine
    • 6.3.3 Cattle
    • 6.3.4 Fish
    • 6.3.5 Other livestock animals

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Veterinary hospital pharmacy
  • 7.3 E-commerce
  • 7.4 Retail pharmacy

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Poland
    • 8.3.7 Netherlands
    • 8.3.8 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Taiwan
    • 8.4.7 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 GCC Countries
    • 8.6.3 Israel
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 B. Braun Vet Care (B Braun Melsungen AG)
  • 9.2 Boehringer Ingelheim International GmbH
  • 9.3 Ceva Sante Animale
  • 9.4 Dechra Pharmaceuticals
  • 9.5 Elanco Animal Health
  • 9.6 Endovac Animal Health
  • 9.7 HIPRA
  • 9.8 IDEXX Laboratories
  • 9.9 Merck and Co
  • 9.10 Medtronic plc
  • 9.11 Neogen Corporation
  • 9.12 Sklar Surgical Instruments
  • 9.13 Symrise
  • 9.14 Vetoquinol SA
  • 9.15 Virbac SA
  • 9.16 Zoetis, Inc.